VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation

Cancer Research

Volumn 74, Issue 5, 2014, Pages 1566-1575

  Fantozzi, Anna ^a,e   Gruber, Dorothea C ^a,f   Pisarsky, Laura ^a   Heck, Chantal ^a   Kunita, Akiko ^a,c   Yilmaz, Mahmut ^a,d   Meyer Schaller, Nathalie ^a   Cornille, Karen ^b   Hopfer, Ulrike ^a,e   Bentires Alj, Mohamed ^b   Christofori, Gerhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c UNIVERSITY OF TOKYO   (Japan)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e NOVARTIS PHARMA AG   (Switzerland)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER STEM CELL; CELL POPULATION; CONTROLLED STUDY; DISEASE ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; IN VITRO STUDY; LUNG METASTASIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CARCINOGENESIS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; MICE; MICE, INBRED BALB C; NEOPLASTIC STEM CELLS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896498641     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1641     Document Type: Article

References (26)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
2. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274-84.
3. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-73.
4. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
5. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
6. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY , et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
7. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008;3:e2888.
8. Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012;10:717-28.
9. Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D , et al. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 2008;27:2603-15.
10. Waldmeier L, Meyer-Schaller N, Diepenbruck M, Christofori G. Py2T Murine breast cancer cells, a versatile model of TGFbeta-induced EMT in vitro and in vivo. PLoS ONE 2012;7:e48651.
11. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ , et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17: 1253-70.
12. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA , et al. Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 2009;138:645-59.
13. Baccelli I, Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol 2012;198:281-93.
14. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH , et al. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006;8:R59.
15. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenicmice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985;315:115-22.
16. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O , et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-4.
17. Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A , et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 2011;478:399-403.
18. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT , et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 2011;17:1514-20.
19. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-8.
20. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008; 8:755-68.
21. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006;66: 7843-8.
22. Lee J, Lee J, Yu H, Choi K, Choi C. Differential dependency of human cancer cells on vascular endothelial growth factor-mediated autocrine growth and survival. Cancer Lett 2011;309:145-50.
23. Lee J, Ku T, Yu H, Chong K, Ryu SW, Choi K, et al. Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT. Cancer Lett 2012;318:221-5.
24. Salva E, Kabasakal L, Eren F, Ozkan N, Cakalagaoglu F, Akbuga J. Local delivery of chitosan/VEGF siRNA nanoplexes reduces angiogenesis and growth of breast cancer in vivo. Nucleic Acid Ther 2012;22:40-8.
25. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009;347:70-8.
26. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-Tomesenchyme transition. J Cell Sci 2005;118:873-87.